Literature DB >> 29318710

Evaluation of three hormonal protocols for anovulatory lactating cows under regulations restricting the use of estrogenic compounds.

Guang-Min Yu1,2,3, Yue Wu1, Xian-Long Wang4, Shuan Zhao1, Teruo Maeda3, Shen-Ming Zeng1.   

Abstract

When European Union regulations restricted the use of estrogenic compounds in food-producing animals, refined hormonal protocols were no longer applicable for anovulatory cows. However, Ovsynch and its adaptations are routinely and uniformly applied to all cows regardless of ovarian function. To evaluate their efficacy on anovulatory cows, 143, 147 and 144 anovulatory cows received Ovsynch, Presynch and G6G protocols, respectively. In comparison, 150 cyclic cows were bred without using a synchronized protocol. Results showed that cows in the Presynch group had luteolysis responding to the last prostaglandin F2α (PGF2α ) injection greater than the Ovsynch group. The serous progesterone levels at the first gonadotropin-releasing hormone of Ovsych and the last PGF2α injection was greater in the G6G group than the other two hormonal treatment groups. Concentrations of Ca2+ and total protein in cervical mucus in all three hormone-treated groups before artificial insemination (AI) were significantly different from the controls. The G6G group obtained a greater pregnancy rate compared with Ovsynch and Presynch, but significantly less than the controls. For open cows in the Ovsynch group, estrus rate within 24 days after the first AI was significantly less than the controls. In conclusion, the G6G treatment resulted to better reproductive performance in anovulatory cows.
© 2018 Japanese Society of Animal Science.

Entities:  

Keywords:  anovulation; cervical mucus; estrogenic compound; estrus rate; synchronized protocol

Mesh:

Substances:

Year:  2018        PMID: 29318710     DOI: 10.1111/asj.12953

Source DB:  PubMed          Journal:  Anim Sci J        ISSN: 1344-3941            Impact factor:   1.749


  1 in total

1.  The antioxidant effect of triptolide contributes to the therapy in a collagen-induced arthritis rat model.

Authors:  Guang-Min Yu; Li-Feng Zhou; Bi-Xia Zeng; Jing-Jun Huang; Xiao-Jun She
Journal:  Redox Rep       Date:  2021-12       Impact factor: 4.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.